Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027318	s-etglygc	— (—)	99	107	100.00%	Distribution not available
3027318	s-etglygc	mmol/l (mmol/l)	36	37	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

58.48

158.86

1.1

1.0

—

mmol/l

—

100

58.11

158.31

1.1

1.0

—

mmol/l

—

Alcohol use disorder, Swedish definition

57.09

154.06

1.1

—

mmol/l

—

Substance abuse

44.69

152.85

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to psychoactive substance use

42.40

150.90

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to alcohol

48.27

150.30

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

49.72

145.96

1.1

—

mmol/l

—

Substance abuse, excluding more controls

50.25

143.19

1.1

1.0

—

mmol/l

—

Alcohol use disorder, ICD-based

49.00

143.16

1.1

—

mmol/l

—

Alcohol dependence

52.95

101.41

1.2

1.0

—

mmol/l

—

Acute alcohol intoxication, ICD10

35.89

79.76

1.2

1.0

—

mmol/l

—

Poisoning by medicine

32.81

76.20

1.2

1.1

—

mmol/l

—

Poisoning by drugs, medicaments and biological substances

30.74

74.72

1.2

1.1

—

mmol/l

—

Persons encountering health services in other circumstances

18.84

71.82

1.2

1.0

—

mmol/l

—

Suicide or other Intentional self-harm

22.18

57.01

1.2

1.1

—

mmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

18.74

54.35

1.2

1.0

—

mmol/l

—

Other disorders of fluid, electrolyte and acid-base balance

18.88

53.66

1.2

—

mmol/l

—

Mood disorders, excluding more controls

16.46

46.66

1.2

1.0

—

mmol/l

—

Acute alcohol intoxication

59.11

45.29

1.2

1.0

—

mmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

9.39

42.49

1.1

—

mmol/l

—

Benzodiazepine use

7.65

40.43

1.1

—

mmol/l

—

Implicit Sepsis

9.43

39.75

1.1

—

mmol/l

—

Implicit Sepsis, including avohilmo

8.85

38.83

1.1

—

mmol/l

—

Any mental disorder

12.98

38.44

1.2

1.0

—

mmol/l

—

Bacterial Sepsis

12.41

38.34

1.1

—

mmol/l

—

Implicit bacterial Sepsis, including avohilmo

12.64

37.95

1.1

—

mmol/l

—

Alcohol abuse, main dg, excluding more controls

70.24

36.94

1.2

1.0

—

mmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

8.13

36.71

1.2

1.1

—

mmol/l

—

Intracranial trauma

11.96

36.41

1.2

1.1

—

mmol/l

—

Concussion

12.23

35.74

1.1

—

mmol/l

—

Implicit bacterial Sepsis

12.54

35.63

1.1

1.2

—

mmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

42.53

34.70

1.2

1.0

—

mmol/l

—

Intracranial injury

8.56

34.24

1.1

1.0

—

mmol/l

—

Mood [affective] disorders

6.73

32.99

1.2

1.1

—

mmol/l

—

Mood disorders

6.71

32.91

1.2

1.0

—

mmol/l

—

Depression

6.92

32.85

1.2

1.1

—

mmol/l

—

Alcohol abuse, main dg

35.19

32.73

1.2

1.0

—

mmol/l

—

Open wound of head

8.77

32.67

1.2

1.0

—

mmol/l

—

Substance use, excluding alcohol

53.03

31.25

1.2

1.0

—

mmol/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

30.91

30.29

1.3

1.1

—

mmol/l

—

Exposure to unspecified factor

6.10

30.25

1.1

—

mmol/l

—

Disorders of adult personality and behaviour

11.06

30.19

1.2

1.1

—

mmol/l

—

Anxiety (asthma-related co-morbidities)

16.29

29.71

1.3

1.0

—

mmol/l

—

Personality disorders

11.09

29.31

1.2

1.1

—

mmol/l

—

Other antidepressants

8.11

28.66

1.1

—

mmol/l

—

Fall on same level

6.20

28.55

1.2

1.1

—

mmol/l

—

Psychiatric diseases

11.97

27.99

1.2

1.0

—

mmol/l

—

Injuries to the head

5.93

27.22

1.2

1.0

—

mmol/l

—

Problems related to lifestyle

62.35

26.94

1.2

1.0

—

mmol/l

—

Selective serotonin reuptake inhibitors

7.58

26.16

1.1

—

mmol/l

—

Anxiety disorders, excluding more controls

11.43

25.38

1.2

1.0

—

mmol/l

—

Falls/tendency to fall

6.99

25.12

1.2

1.1

—

mmol/l

—

Personality disorders, excluding more controls

30.99

23.62

1.2

1.0

—

mmol/l

—

Invasive ventilation

47.04

23.32

1.0

—

mmol/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

8.35

23.10

1.2

1.1

—

mmol/l

—

Renal failure

7.46

22.91

1.0

1.3

—

mmol/l

—

Depression or dysthymia

14.90

22.80

1.1

1.0

—

mmol/l

—

Schizophrenia or delusion

8.30

22.22

1.1

1.2

—

mmol/l

—

Schizophrenia, schizotypal and delusional disorders

8.30

22.22

1.1

1.2

—

mmol/l

—

Schizophrenia or delusion, excluding more controls

31.86

22.21

1.1

1.0

—

mmol/l

—

Persons encountering health services in other circumstances, wide

5.54

21.92

1.2

1.0

—

mmol/l

—

Use of hypnotics and sedatives

5.07

21.20

1.2

1.0

—

mmol/l

—

Renal tubulo-interstitial diseases

5.30

21.11

1.0

1.2

—

mmol/l

—

Malaise and fatigue

7.24

20.95

1.1

—

mmol/l

—

Acute renal failure

17.27

19.96

1.0

1.3

—

mmol/l

—

Diseases of liver

7.19

19.04

1.0

1.2

—

mmol/l

—

All kidney diseases

4.50

17.82

1.1

—

mmol/l

—

Specific personality disorders

13.67

17.70

1.2

—

mmol/l

—

Pneumonia, organism unspecified

4.48

17.17

1.1

—

mmol/l

—

Metabolic disorders

4.76

17.03

1.2

1.1

—

mmol/l

—

Use of disulfiram, acamprosate or naltrexone

25.69

16.88

1.2

1.0

—

mmol/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.29

16.86

1.1

—

mmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

35.21

16.66

1.2

—

mmol/l

—

Alcohol withdrawal state with delirium

27.70

16.49

1.2

1.0

—

mmol/l

—

Emotionally unstable personality disorder

27.59

16.47

1.2

1.3

—

mmol/l

—

Mental and behavioural disorders due to sedatives or hypnotics

40.30

16.32

1.2

—

mmol/l

—

Other anxiety disorders

6.44

16.18

1.3

1.1

—

mmol/l

—

Pneumonias (Asthma/COPD co-morbidities)

4.15

16.11

1.1

—

mmol/l

—

All pneumoniae

4.13

15.98

1.1

—

mmol/l

—

Volume depletion

33.46

15.72

1.0

1.2

—

mmol/l

—

Unspecified mental disorder

5.84

15.67

1.1

1.2

—

mmol/l

—

Bleeding

4.60

15.23

1.1

—

mmol/l

—

Kela-code for severe mental illness

6.26

14.98

1.1

1.2

—

mmol/l

—

Other bacterial diseases, including avohilmo

4.07

14.86

1.1

—

mmol/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4.70

14.85

1.1

—

mmol/l

—

4.70

14.85

1.1

—

mmol/l

—

Other bacterial diseases

4.16

14.61

1.1

—

mmol/l

—

Influenza and pneumonia

3.87

13.87

1.1

—

mmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

20.07

13.76

1.4

1.1

—

mmol/l

—

Explicit Sepsis

6.68

13.51

1.0

1.1

—

mmol/l

—

Other symptoms and signs involving cognitive functions and awareness

5.62

13.43

1.2

1.1

—

mmol/l

—

Explicit Sepsis, including avohilmo

6.65

13.43

1.0

1.1

—

mmol/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.78

12.72

1.2

1.1

—

mmol/l

—

Persons encountering health services for specific procedures, not carried out

32.11

12.56

1.1

1.0

—

mmol/l

—

Recurrent or chronic depression

21.97

12.18

1.0

—

mmol/l

—

Any death

4.57

12.14

1.0

1.2

—

mmol/l

—

General symptoms and signs

4.11

12.02

1.2

1.0

—

mmol/l

—

Hypo-osmolality and hyponatraemia

14.52

11.70

1.2

1.1

—

mmol/l

—

All anxiety disorders

4.37

11.63

1.3

1.1

—

mmol/l

—

Septicaemia

5.57

11.39

1.0

1.1

—

mmol/l

—

Convulsions, not elsewhere classified

9.46

11.11

1.1

1.0

—

mmol/l

—

Neurotic, stress-related and somatoform disorders

3.58

10.88

1.2

1.0

—

mmol/l

—

Type of accident

8.22

10.77

1.3

1.1

—

mmol/l

—

Other septicaemia, including avohilmo

5.69

10.69

1.1

1.2

—

mmol/l

—

Other and unspecified myopathies

21.50

10.67

1.1

—

mmol/l

—

Other external causes of accidental injury

6.33

10.66

1.3

1.0

—

mmol/l

—

Other specified and unspecified personality disorders

18.81

10.25

1.2

1.1

—

mmol/l

—

Alcoholic liver disease

18.81

10.25

1.0

1.3

—

mmol/l

—

Anxiety disorders

3.43

10.23

1.2

1.0

—

mmol/l

—

Unspecified fall

4.08

10.02

1.1

—

mmol/l

—

Accidents

6.06

9.88

1.3

1.0

—

mmol/l

—

Pneumonitis due to solids and liquids

16.73

9.86

1.2

1.1

—

mmol/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

26.09

9.81

1.4

1.0

—

mmol/l

—

Bacterial infection, other or unspecified, including avohilmo

4.45

9.79

1.0

1.1

—

mmol/l

—

Chronic apical periodontitis

3.20

9.77

1.2

1.1

—

mmol/l

—

Diseases of the myoneural junction and muscle

13.37

9.65

1.1

—

mmol/l

—

Hypokalaemia

13.37

9.65

1.1

1.2

—

mmol/l

—

Lung diseases due to external agents

13.36

9.65

1.2

1.3

—

mmol/l

—

Delirium, not induced by alcohol and other psychoactive substances

17.49

9.37

1.2

1.0

—

mmol/l

—

21.73

9.34

1.0

—

mmol/l

—

Bacterial infection, other or unspecified

4.51

9.24

1.0

1.1

—

mmol/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

11.45

9.05

1.1

1.3

—

mmol/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

3.75

9.02

1.1

—

mmol/l

—

Other and unspecified effects of external causes

7.01

8.99

1.0

1.3

—

mmol/l

—

Diabetes mellitus

3.17

8.66

1.2

1.1

—

mmol/l

—

Dental pulpitis, including avohilmo

3.08

8.57

1.2

1.1

—

mmol/l

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.54

8.57

1.1

1.0

—

mmol/l

—

Other and unspecified nonorganic psychotic disorders

8.19

8.55

1.0

1.2

—

mmol/l

—

Infections of the skin and subcutaneous tissue

3.40

8.37

1.2

1.1

—

mmol/l

—

severe traumatic brain injury, does not include concussion

7.84

8.34

1.1

1.2

—

mmol/l

—

Viral hepatitis, IBD co-morbidity

+∞

8.33

1.1

0.0

—

mmol/l

—

Diabetes, varying definitions

3.06

8.01

1.2

1.1

—

mmol/l

—

Epilepsy

6.24

7.96

1.0

1.2

—

mmol/l

—

Acute pancreatitis

7.74

7.85

1.2

—

mmol/l

—

Non-selective monoamine reuptake inhibitors

7.77

7.82

1.1

—

mmol/l

—

Leisure time condition

8.43

7.79

1.4

1.3

—

mmol/l

—

Traumatic subdural haemorrhage

16.05

7.76

1.1

1.3

—

mmol/l

—

Other septicaemia

6.08

7.76

1.1

1.2

—

mmol/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.14

7.76

1.2

1.1

—

mmol/l

—

Event of undetermined intent

15.05

7.71

1.1

1.0

—

mmol/l

—

Other reaction to severe stress, and adjustment disorders

6.66

7.56

1.2

1.1

—

mmol/l

—

Persons encountering health services for specific procedures and health care

2.84

7.54

1.1

—

mmol/l

—

Acute pancreatitis (for exclusion)

7.09

7.46

1.2

—

mmol/l

—

Endocrine, nutritional and metabolic diseases

3.72

7.41

1.2

1.1

—

mmol/l

—

Cutaneous abscess, furuncle and carbuncle

6.44

7.39

1.2

1.1

—

mmol/l

—

Organic, including symptomatic, mental disorders

4.07

7.39

1.1

—

mmol/l

—

Insulin medication

3.52

7.28

1.2

1.1

—

mmol/l

—

Parasetamol

3.87

7.22

1.2

1.1

—

mmol/l

—

Erysipelas, including avohilmo

3.39

7.22

1.2

1.1

—

mmol/l

—

Erysipelas

3.94

7.22

1.2

1.1

—

mmol/l

—

Nausea and vomiting

6.64

7.12

1.2

1.1

—

mmol/l

—

Fever of other and unknown origin

4.03

7.10

1.2

1.0

—

mmol/l

—

Bipolar affective disorders

8.76

7.03

1.3

1.1

—

mmol/l

—

Injuries to the thorax

3.61

6.99

1.3

1.1

—

mmol/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

3.33

6.91

1.2

1.1

—

mmol/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

2.80

6.91

1.1

—

mmol/l

—

Intestinal infectious diseases

2.77

6.76

1.2

1.1

—

mmol/l

—

Alcohol-induced chronic pancreatitis

16.73

6.74

1.3

1.0

—

mmol/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.97

6.72

1.2

1.1

—

mmol/l

—

All chronic kidney diseases

3.89

6.62

1.0

1.2

—

mmol/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

4.00

6.61

1.2

—

mmol/l

—

Insulin, intermediate and long-acting

3.36

6.55

1.2

1.1

—

mmol/l

—

Antihypertensive medication - note that there are other indications

4.35

6.48

1.1

1.2

—

mmol/l

—

Codeine

2.87

6.38

1.2

1.1

—

mmol/l

—

Nutritional anaemias

3.77

6.37

1.1

1.2

—

mmol/l

—

Chronic pancreatitis

11.02

6.29

1.3

—

mmol/l

—

Heart failure and antihypertensive medication

14.29

6.26

1.0

1.4

—

mmol/l

—

Diseases of pulp and periapical tissues, including avohilmo

2.95

6.21

1.2

1.1

—

mmol/l

—

Type 2 diabetes, wide definition

3.15

6.20

1.2

1.0

—

mmol/l

—

Implicit viral Sepsis, including avohilmo

6.99

6.19

1.1

1.2

—

mmol/l

—

Heart failure, not strict

3.03

6.18

1.1

1.2

—

mmol/l

—

Assault

7.66

6.11

1.0

1.3

—

mmol/l

—

Sleep disorders

2.70

6.03

1.1

—

mmol/l

—

Pain in throat and chest

2.91

5.96

1.2

1.0

—

mmol/l

—

Aplastic and other anaemias

3.74

5.91

1.1

1.2

—

mmol/l

—

Other ill-defined and unspecified causes of mortality

15.02

5.90

1.0

—

mmol/l

—

Fracture of rib(s), sternum and thoracic spine

4.00

5.89

1.3

1.1

—

mmol/l

—

Asthma, unspecified (mode)

3.94

5.88

1.0

1.2

—

mmol/l

—

Fracture of femur

5.88

5.80

1.2

1.1

—

mmol/l

—

Certain infectious and parasitic diseases

3.03

5.80

1.2

1.0

—

mmol/l

—

Transport accidents

6.47

5.72

1.1

1.0

—

mmol/l

—

STROKE

3.91

5.69

1.1

—

mmol/l

—

Diagnoses used for exclusion with ILD

5.17

5.68

1.2

1.3

—

mmol/l

—

Cardiovascular diseases (excluding rheumatic etc)

3.37

5.66

1.2

—

mmol/l

—

Disorders of gallbladder, biliary tract and pancreas

2.69

5.65

1.1

—

mmol/l

—

Diabetes medication

2.59

5.64

1.1

—

mmol/l

—

Other disorders of urethra and urinary system

3.20

5.59

1.1

—

mmol/l

—

Other viral hepatitis, including avohilmo

12.89

5.58

1.1

—

mmol/l

—

Ill-defined and unknown causes of mortality

12.88

5.58

1.0

—

mmol/l

—

Hypertensive diseases (excluding secondary)

3.81

5.53

1.2

—

mmol/l

—

Type 2 diabetes

2.68

5.51

1.2

1.1

—

mmol/l

—

Insulin, fast-acting

3.62

5.46

1.1

—

mmol/l

—

Diabetes, insulin treatment (Kela reimbursement)

2.56

5.41

1.1

—

mmol/l

—

Other and unspecified anaemias

3.63

5.40

1.1

1.2

—

mmol/l

—

Other anaemias

3.62

5.37

1.1

1.2

—

mmol/l

—

Persistent mood disorders

7.86

5.33

1.1

—

mmol/l

—

External causes of morbidity and mortality

6.26

5.32

1.3

1.0

—

mmol/l

—

Insomnia

2.60

5.30

1.1

—

mmol/l

—

Maltreatment syndromes

11.29

5.29

1.1

1.3

—

mmol/l

—

Viral hepatitis, including avohilmo

11.28

5.29

1.1

—

mmol/l

—

COPD/asthma/ILD related infections

2.85

5.28

1.1

—

mmol/l

—

COPD/asthma related infections

2.85

5.28

1.1

—

mmol/l

—

Diseases of the digestive system

3.37

5.22

1.2

1.1

—

mmol/l

—

Folate deficiency anaemia

+∞

5.22

1.0

0.0

—

mmol/l

—

Toxic effect of other and unspecified substances

+∞

5.21

1.4

0.0

—

mmol/l

—

Insulin, fast-acting or short human

3.47

5.15

1.1

—

mmol/l

—

Implicit viral Sepsis

7.34

5.13

1.1

—

mmol/l

—

Viral Sepsis

7.34

5.13

1.1

—

mmol/l

—

Chronic viral hepatitis

13.37

5.08

1.1

1.0

—

mmol/l

—

Mixed and other personality disorders

13.36

5.08

1.4

1.2

—

mmol/l

—

Asthma, unspecified (mode), excluding more controls

3.82

5.03

1.0

1.2

—

mmol/l

—

Nonorganic sleeping disorders, excluding more controls

10.01

5.02

1.1

1.0

—

mmol/l

—

Any reimbursement code in KELA

3.66

4.98

1.2

1.0

—

mmol/l

—

Cerebrovascular diseases (FINNGEN)

6.07

4.97

1.1

1.2

—

mmol/l

—

Fracture of lower leg, including ankle

2.88

4.95

1.2

1.1

—

mmol/l

—

Tramadol

2.70

4.80

1.1

—

mmol/l

—

Other diseases of the digestive system

4.41

4.73

1.3

1.1

—

mmol/l

—

GI-bleeding

4.41

4.73

1.3

1.1

—

mmol/l

—

Cardiovascular diseases

3.32

4.71

1.2

1.1

—

mmol/l

—

Headache

3.12

4.62

1.1

1.0

—

mmol/l

—

Type 1 diabetes

5.00

4.61

1.2

1.1

—

mmol/l

—

14.01

4.57

1.1

1.0

—

mmol/l

—

Exposure to other specified factors

2.45

4.54

1.1

—

mmol/l

—

Injury, poisoning and certain other consequences of external causes

5.92

4.53

1.2

1.0

—

mmol/l

—

Other viral hepatitis

10.02

4.52

1.1

—

mmol/l

—

Disorders of mineral metabolism

10.02

4.52

1.1

—

mmol/l

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.32

4.46

1.2

1.1

—

mmol/l

—

Other diseases of liver

5.80

4.43

1.0

1.4

—

mmol/l

—

Type 2 diabetes, strict (exclude DM1)

2.54

4.43

1.2

1.1

—

mmol/l

—

Abnormalities of heart beat

4.38

4.41

1.1

—

mmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.98

4.32

1.1

—

mmol/l

—

Cystitis

2.65

4.31

1.2

1.1

—

mmol/l

—

Gout, idiopatic and unspecified

5.00

4.31

1.1

1.2

—

mmol/l

—

Viral hepatitis

8.91

4.28

1.1

—

mmol/l

—

Open wound of forearm

8.90

4.28

1.0

1.1

—

mmol/l

—

Decubitus ulcer and pressure area

11.69

4.27

1.0

—

mmol/l

—

Unspecified kidney failure

11.68

4.27

1.0

1.5

—

mmol/l

—

Neurological diseases, wide definition

6.91

4.27

1.2

1.0

—

mmol/l

—

Injuries to the hip and thigh

2.99

4.25

1.2

1.1

—

mmol/l

—

Injuries to the wrist and hand

2.28

4.20

1.1

—

mmol/l

—

Heart failure and bmi 25plus

3.73

4.20

1.0

1.2

—

mmol/l

—

Codeine or tramadol medication

2.24

4.18

1.2

1.1

—

mmol/l

—

Obesity due to excess calories

2.90

4.16

1.1

1.2

—

mmol/l

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.29

4.15

1.1

—

mmol/l

—

Other nutritional deficiencies

2.56

4.14

1.1

—

mmol/l

—

Other heart diseases, wide

2.36

4.14

1.2

1.1

—

mmol/l

—

Type 2 diabetes, definitions combined

2.49

4.13

1.2

1.1

—

mmol/l

—

Early onset COPD, excluding more controls

5.88

4.12

1.0

1.3

—

mmol/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

4.34

4.12

1.0

1.2

—

mmol/l

—

Atrial fibrillation and flutter with reimbursement

8.10

4.11

1.0

1.1

—

mmol/l

—

Gout, FINNGEN

4.31

4.09

1.2

1.1

—

mmol/l

—

Hypertension, essential

2.71

4.06

1.2

1.1

—

mmol/l

—

Duodenal ulcer

8.01

4.06

1.4

1.0

—

mmol/l

—

Fall on and from stairs and steps

4.62

4.05

1.2

1.3

—

mmol/l

—

Syncope and collapse

3.44

4.03

1.2

1.1

—

mmol/l

—

Sequelae of injuries of upper limb

10.01

4.01

1.0

—

mmol/l

—

Heart failure,strict

2.99

4.00

1.0

1.2

—

mmol/l

—

Schizophrenia

5.01

4.00

1.2

—

mmol/l

—

Gout

4.29

3.99

1.2

—

mmol/l

—

Persons with potential health hazards related to communicable diseases

3.16

3.98

1.4

1.1

—

mmol/l

—

Secondary hypertension

9.86

3.97

1.0

1.4

—

mmol/l

—

Superficial injury of head

5.55

3.96

1.4

1.1

—

mmol/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.15

3.95

1.0

1.3

—

mmol/l

—

Fracture at wrist and hand level

3.01

3.93

1.1

—

mmol/l

—

Hyperlipidaemia, other/unspecified

4.17

3.92

1.1

—

mmol/l

—

Disorders of psychological development

5.46

3.87

1.1

1.0

—

Any gastric operation

2.68

3.86

1.2

1.0

—

mmol/l

—

GASTRO-related operations

2.68

3.86

1.2

1.0

—

mmol/l

—

Care involving use of rehabilitation procedures

2.64

3.83

1.1

—

mmol/l

—

Gout, strict definition

5.27

3.82

1.1

1.2

—

mmol/l

—

Gout, unspecified

5.27

3.82

1.1

—

mmol/l

—

Extreme obesity with alveolar hypoventilation

12.04

3.76

1.2

1.0

—

mmol/l

—

Other heart diseases

3.25

3.71

1.0

1.2

—

mmol/l

—

Autoimmune diseases

2.16

3.70

1.1

—

mmol/l

—

Other fall from one level to another

4.14

3.69

1.1

1.2

—

mmol/l

—

Cardiac arrhythmias

3.11

3.69

1.1

—

mmol/l

—

Dialysis, with operation codes

6.67

3.67

1.0

1.4

—

mmol/l

—

Hard cardiovascular diseases

2.42

3.65

1.1

—

mmol/l

—

Hypertensive diseases

2.54

3.65

1.2

—

mmol/l

—

Hypertension

2.54

3.65

1.2

—

mmol/l

—

Symptoms and signs involving the digestive system and abdomen

2.34

3.63

1.3

1.0

—

mmol/l

—

Asthma, excluding more controls

2.98

3.63

1.0

1.2

—

mmol/l

—

Other (not insulin) diabetes medications

2.28

3.61

1.1

—

mmol/l

—

Acute tubulo-interstitial nephritis

2.81

3.60

1.1

1.2

—

mmol/l

—

Heart failure, strict

2.69

3.56

1.0

1.2

—

mmol/l

—

Schizoaffective disorder

7.79

3.56

1.0

1.1

—

mmol/l

—

Assault by bodily force

7.79

3.56

1.0

1.1

—

mmol/l

—

Other disorders of glucose regulation and pancreatic internal secretion

7.79

3.55

1.0

1.1

—

mmol/l

—

Ascites

10.01

3.49

1.3

1.0

—

mmol/l

—

Neurological diseases

2.51

3.45

1.1

—

mmol/l

—

Pain, not elsewhere classified

4.55

3.42

1.1

1.0

—

mmol/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.84

3.36

1.1

—

mmol/l

—

Symptoms and signs involving the urinary system

2.34

3.36

1.1

—

mmol/l

—

Diseases of the skin and subcutaneous tissue

2.20

3.34

1.2

1.1

—

mmol/l

—

Medical abortion

2.99

3.31

1.1

—

mmol/l

—

Injuries to the ankle and foot

2.25

3.30

1.0

1.1

—

mmol/l

—

Mental and behavioural disorders due to tobacco

8.58

3.26

1.0

—

Bronchitis

2.06

3.22

1.1

—

mmol/l

—

Periapical abscess

2.58

3.20

1.2

1.1

—

mmol/l

—

All-cause Heart Failure

2.61

3.20

1.0

1.2

—

mmol/l

—

Factors influencing health status and contact with health services

5.65

3.19

1.1

1.0

—

mmol/l

—

Cellulitis

4.17

3.19

1.2

—

mmol/l

—

Acute and transient psychotic disorders

5.34

3.19

1.1

1.3

—

mmol/l

—

Exclusions for E4_PCOS_CONSORTIUM

2.50

3.18

1.2

1.1

—

mmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

2.26

3.17

1.2

1.1

—

mmol/l

—

Chronic kidney disease

3.78

3.15

1.0

1.3

—

mmol/l

—

Sleep disorders (combined)

2.13

3.14

1.1

—

mmol/l

—

Asthma (mode)

2.70

3.14

1.0

1.1

—

mmol/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.09

3.14

1.1

—

mmol/l

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2.00

3.09

1.2

1.1

—

mmol/l

—

Spondyloarthritis

4.00

3.08

1.2

1.3

—

mmol/l

—

Caries of dentine

4.02

3.07

1.1

—

mmol/l

—

Episodal and paroxysmal disorders

2.08

3.06

1.1

—

mmol/l

—

Asthma

2.65

3.03

1.0

1.1

—

mmol/l

—

Injuries to the knee and lower leg

1.98

3.02

1.1

—

mmol/l

—

Cirrhosis of liver, NAS

10.02

2.98

1.0

—

mmol/l

—

Post-traumatic stress disorder

10.01

2.98

1.0

1.4

—

Other and unspecified injuries of head

10.01

2.98

1.2

—

Iron deficiency anaemia

3.11

2.97

1.2

—

mmol/l

—

Abdominal and pelvic pain

2.18

2.94

1.2

1.0

—

mmol/l

—

Nonalcoholic fatty liver disease

5.39

2.87

1.0

1.2

—

mmol/l

—

Nephropathy related operations

5.39

2.87

1.0

1.2

—

mmol/l

—

Hypoglycaemia, other or unspecified

6.68

2.86

1.0

1.1

—

Panic disorder

6.67

2.86

1.0

1.2

—

Other pulmonary diagnosis

2.58

2.86

1.2

1.1

—

mmol/l

—

Phobic anxiety disorders

6.65

2.86

1.0

1.2

—

mmol/l

—

Injuries to the elbow and forearm

2.17

2.81

1.0

1.1

—

mmol/l

—

Superficial injury of abdomen, lower back and pelvis

4.45

2.79

1.1

1.2

—

mmol/l

—

Dysphagia

4.45

2.79

1.1

—

mmol/l

—

Sub-endpoint used in defining T1D endpoints

3.11

2.79

1.2

—

mmol/l

—

Missing teeth due to accident, extraction or parodontitis

2.29

2.78

1.2

1.1

—

mmol/l

—

Bacterial pneumoniae

2.78

2.76

1.0

1.2

—

mmol/l

—

Infections, IBD-co-morbidities

7.03

2.75

1.2

1.0

—

mmol/l

—

Fibrosis and cirrhosis of liver

8.34

2.75

1.0

—

mmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.52

2.75

1.1

1.0

—

mmol/l

—

Other soft tissue disorders, not elsewhere classified

2.05

2.74

1.2

1.1

—

mmol/l

—

Abnormal involuntary movements

5.00

2.72

1.3

1.2

—

Certain infectious and parasitic diseases, including avohilmo

2.58

2.72

1.3

1.1

—

mmol/l

—

Fall on same level involving ice and snow

2.23

2.69

1.2

1.1

—

mmol/l

—

Other noninfective gastroenteritis and colitis

3.45

2.68

1.0

1.3

—

mmol/l

—

Asthma (only as main-diagnosis), excluding more controls

2.67

2.64

1.0

1.2

—

mmol/l

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.96

2.63

1.1

—

mmol/l

—

Symptoms and signs involving the circulatory and respiratory systems

2.07

2.63

1.3

1.0

—

mmol/l

—

Autoimmune diseases excluding thyroid diseases

1.96

2.63

1.1

—

mmol/l

—

Asthma (only as main-diagnosis)

2.55

2.61

1.0

1.1

—

mmol/l

—

Complications of surgical and medical care, not elsewhere classified

1.94

2.60

1.0

1.1

—

mmol/l

—

Haemorrhage from respiratory passages

3.14

2.59

1.1

—

mmol/l

—

Other and unspecified iron deficiency

3.33

2.59

1.0

1.2

—

mmol/l

—

Used for control exclusion in common control thyroid runs

1.94

2.58

1.1

—

mmol/l

—

Nonorganic sleeping disorders

3.60

2.57

1.1

1.2

—

mmol/l

—

Spondylopathies (FG)

4.00

2.56

1.3

—

mmol/l

—

Injury of other and unspecified intrathoracic organs

7.15

2.55

1.2

1.0

—

mmol/l

—

Other diseases of pancreas

7.15

2.55

1.4

—

mmol/l

—

Smoking dependency

5.46

2.54

1.0

—

Intracerebral haemorrhage

5.46

2.54

1.0

1.2

—

mmol/l

—

Undetermined asthma

5.45

2.54

1.0

1.4

—

mmol/l

—

Undetermined asthma, excluding more controls

5.45

2.54

1.0

1.4

—

mmol/l

—

Fracture of shoulder and upper arm

2.85

2.53

1.4

1.0

—

mmol/l

—

Early onset COPD

3.23

2.51

1.0

1.3

—

mmol/l

—

General examination and investigation of persons without complaint and reported diagnosis

2.26

2.51

1.2

1.0

—

mmol/l

—

Other diseases of urinary system

2.00

2.50

1.1

—

mmol/l

—

Other CVD (FINNGEN)

7.63

2.50

1.0

1.2

—

mmol/l

—

Other condition

4.38

2.47

1.0

1.3

—

mmol/l

—

Genitourinary diseases

2.44

2.46

1.0

1.1

—

mmol/l

—

Other diseases of the respiratory system

3.81

2.46

1.1

1.2

—

mmol/l

—

Other respiratory disorders and diseases

3.81

2.46

1.1

1.2

—

mmol/l

—

Gastrointestinal diseases

2.59

2.44

1.2

1.0

—

mmol/l

—

Dental caries

3.15

2.43

1.1

—

mmol/l

—

COPD (mode)

3.51

2.42

1.0

1.3

—

mmol/l

—

Biguanides

1.99

2.41

1.1

—

mmol/l

—

Bitten or struck by other mammals

5.00

2.40

1.2

1.3

—

mmol/l

—

Obesity

2.13

2.40

1.1

—

mmol/l

—

Type 1 diabetes, strict (exclude DM2)

4.99

2.39

1.0

1.2

—

mmol/l

—

Type 1 diabetes, definitions combined

4.99

2.39

1.0

1.2

—

mmol/l

—

Obesity and other hyperalimentation

2.13

2.39

1.1

—

mmol/l

—

Constipation

1.98

2.37

1.1

—

mmol/l

—

Explicit bacterial Sepsis

6.25

2.37

1.0

1.1

—

Explicit bacterial Sepsis, including avohilmo

6.25

2.37

1.0

1.1

—

Eating disorder

6.24

2.37

1.4

1.3

—

Migraine without aura

4.12

2.35

1.0

1.2

—

Acetic acid derivatives and related substances

4.14

2.35

1.1

1.0

—

mmol/l

—

All influenza

3.21

2.30

1.1

1.2

—

mmol/l

—

Presence of other functional implants

2.24

2.27

1.2

1.1

—

mmol/l

—

Spondylopathies

2.00

2.27

1.1

—

mmol/l

—

Dizziness and giddiness

2.15

2.26

1.2

1.1

—

mmol/l

—

Contact with and exposure to communicable diseases

2.74

2.25

1.5

1.1

—

mmol/l

—

Fracture of skull and facial bones

3.89

2.25

1.0

1.1

—

mmol/l

—

Cerebral cysts

5.56

2.21

1.0

1.1

—

mmol/l

—

Elevated blood glucose level

5.56

2.21

1.4

1.2

—

mmol/l

—

Glomerulonephritis

5.56

2.21

1.2

1.1

—

mmol/l

—

Secondary uncertain malignant neoplasm

5.56

2.21

1.4

1.0

—

mmol/l

—

Eating disorders

5.55

2.21

1.4

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.14

2.21

1.2

1.0

—

Pain in limb

2.00

2.20

1.1

—

mmol/l

—

Statin medication

2.14

2.19

1.2

—

mmol/l

—

Major coronary heart disease event excluding revascularizations

2.20

2.17

1.2

1.1

—

mmol/l

—

Retention of urine

2.70

2.16

1.2

—

mmol/l

—

Non-ischemic cardiomyopathy

3.10

2.15

1.0

1.3

—

mmol/l

—

Abnormalities of breathing

2.00

2.15

1.1

1.0

—

mmol/l

—

Fracture of foot, except ankle

3.00

2.14

1.1

1.2

—

mmol/l

—

Superficial injury of lower leg

3.00

2.14

1.0

1.2

—

mmol/l

—

Gastroduodenal ulcer

2.99

2.13

1.3

1.1

—

mmol/l

—

Oedema, not elsewhere classified

3.26

2.12

1.0

1.1

—

mmol/l

—

Atrial fibrillation and flutter

3.44

2.10

1.0

1.2

—

mmol/l

—

COPD differential diagnosis

2.29

2.08

1.1

—

mmol/l

—

ILD differential diagnosis

2.29

2.08

1.1

—

mmol/l

—

Excluding asthma or asthma-COPD overlap

2.29

2.08

1.1

—

mmol/l

—

Open wound of wrist and hand

2.20

2.07

1.0

1.1

—

mmol/l

—

Open wound of ankle and foot

5.00

2.07

1.0

—

mmol/l

—

Bacterial pneumonia (organism specified)

2.35

2.06

1.0

1.2

—

mmol/l

—

COPD, hospital admission 2, with asthma infections

2.69

2.02

1.0

1.2

—

mmol/l

—

Paralytic ileus and intestinal obstruction

3.08

2.01

1.0

1.1

—

mmol/l

—

Stroke, excluding SAH

2.14

1.97

1.1

—

mmol/l

—

Opioids

1.88

1.96

1.2

1.1

—

mmol/l

—

Disorders of lipoprotein metabolism and other lipidaemias

2.11

1.95

1.1

—

mmol/l

—

Acute suppurative otitis media

2.59

1.94

1.2

1.1

—

mmol/l

—

Polyarthropathies

2.00

1.94

1.2

1.1

—

mmol/l

—

Ankylosing spondylitis, ICD10

4.55

1.94

1.4

1.2

—

mmol/l

—

Ankylosing spondylitis

4.55

1.94

1.4

—

mmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

3.75

1.93

1.3

—

mmol/l

—

Diseases of pulp and periapical tissues and dental caries

2.26

1.92

1.3

1.0

—

mmol/l

—

Necrosis of pulp, including avohilmo

1.95

1.88

1.2

1.1

—

mmol/l

—

Diseases of oesophagus, stomach and duodenum

1.74

1.88

1.3

1.1

—

mmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

2.12

1.87

1.1

1.2

—

mmol/l

—

COPD related to multimorbidity

2.45

1.87

1.0

1.2

—

mmol/l

—

Intestinal stricture

2.65

1.86

1.2

—

mmol/l

—

Sequelae of external causes of morbidity and mortality

2.86

1.86

1.3

—

mmol/l

—

Suppurative and unspecified otitis media

2.31

1.83

1.2

—

mmol/l

—

Diplopia

3.53

1.83

1.0

1.3

—

mmol/l

—

Other bacterial intestinal infections

3.53

1.83

1.2

1.3

—

mmol/l

—

Ischemic heart diseases

1.89

1.83

1.1

—

mmol/l

—

Superficial injury of forearm

4.17

1.82

1.0

1.2

—

Generalized anxiety disorder

4.16

1.82

1.2

—

Gastro-oesophageal reflux disease

1.95

1.82

1.2

1.1

—

mmol/l

—

Complications of medical and surgical care

1.90

1.81

1.1

—

mmol/l

—

Noninfective enteritis and colitis

2.12

1.81

1.0

1.2

—

mmol/l

—

Injuries to the shoulder and upper arm

1.79

1.80

1.3

1.1

—

mmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

3.04

1.79

1.0

1.3

—

mmol/l

—

Stroke, including SAH

2.05

1.79

1.1

—

mmol/l

—

Oxicams

3.79

1.78

1.2

1.0

—

mmol/l

—

Coxibs

3.34

1.78

1.0

1.1

—

Diseases of the respiratory system

2.33

1.76

1.2

1.1

—

mmol/l

—

Other headache syndromes

2.33

1.76

1.0

1.2

—

Diabetic retinopathy, excluding more controls

2.80

1.75

1.1

1.3

—

mmol/l

—

Superficial injury of thorax

3.34

1.74

1.2

—

mmol/l

—

Focal epilepsy

2.92

1.72

1.0

1.3

—

mmol/l

—

Abnormalities of gait and mobility

3.85

1.71

1.0

1.2

—

Otitis externa, unspecified

3.85

1.71

1.0

1.2

—

mmol/l

—

Hypertensive heart and/or renal disease

3.37

1.69

1.0

1.2

—

mmol/l

—

Disorders of other endocrine glands

2.19

1.67

1.1

1.2

—

mmol/l

—

Other diseases of intestines

1.68

1.66

1.2

1.1

—

mmol/l

—

Viral infections characterized by skin and mucous membrane lesions

2.18

1.66

1.0

1.1

—

mmol/l

—

Other neurological diseases

1.89

1.66

1.1

—

mmol/l

—

Acute upper respiratory infections of multiple and unspecified sites

1.82

1.65

1.1

—

mmol/l

—

Speech and linguistic disorders

3.69

1.65

1.2

1.0

—

Glomerular diseases

2.80

1.65

1.1

1.3

—

mmol/l

—

Functional dyspepsia

2.80

1.65

1.3

1.1

—

mmol/l

—

Other diseases of upper respiratory tract

1.66

1.64

1.1

—

mmol/l

—

Covid-19 confirmed case

2.44

1.64

1.1

1.2

—

mmol/l

—

Insulin, fast-acting (human)

3.57

1.61

1.0

1.1

—

mmol/l

—

Periodontitis

1.69

1.60

1.2

1.1

—

mmol/l

—

Other arthrosis

2.01

1.59

1.0

1.1

—

mmol/l

—

Hernia of abdominal wall

2.06

1.59

1.3

1.1

—

mmol/l

—

Diseases of the eye and adnexa

1.81

1.58

1.2

1.1

—

mmol/l

—

Other CVD

3.00

1.58

1.0

1.1

—

mmol/l

—

Fracture of lumbar spine and pelvis

2.69

1.57

1.0

1.3

—

mmol/l

—

COPD, hospital admissions

2.15

1.57

1.0

1.2

—

mmol/l

—

Other problems related to primary support group, including family circumstances

3.47

1.57

1.0

1.2

—

Bacterial pneumonia, not elsewhere classified

2.31

1.56

1.0

1.2

—

mmol/l

—

Osteoporosis

2.68

1.55

1.0

1.3

—

mmol/l

—

Caries of dentine, including avohilmo

1.93

1.53

1.5

1.0

—

mmol/l

—

Chronic laryngitis and laryngotracheitis

3.33

1.52

1.0

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.58

1.52

1.3

1.2

—

mmol/l

—

Cerebrovascular diseases

1.83

1.51

1.1

—

mmol/l

—

Other retinal disorders

1.90

1.51

1.0

1.2

—

mmol/l

—

Ganglion

2.86

1.50

1.0

1.2

—

Bacterial intestinal infections, IBD co-morbidities

2.86

1.50

1.2

—

mmol/l

—

Type 1 diabetes, wide definition, subgroup 1

2.85

1.50

1.0

—

mmol/l

—

Other viral diseases, not elsewhere classified

2.85

1.50

1.2

1.3

—

mmol/l

—

Myocardial infarction

2.06

1.50

1.2

1.1

—

mmol/l

—

Congenital malformations of the circulatory system

3.24

1.48

1.2

1.1

—

mmol/l

—

Disorders of choroid and retina

1.75

1.46

1.0

1.1

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.13

1.45

1.0

1.1

—

Disorders of synovium and tendon

1.95

1.45

1.0

1.1

—

mmol/l

—

Acute and subacute iridocyclitis

2.73

1.43

1.2

—

mmol/l

—

Anterior Iridocyclitis

2.73

1.43

1.2

1.3

—

mmol/l

—

Focal epilepsy, strict definition

2.73

1.43

1.0

1.3

—

mmol/l

—

COPD, early/later onset

2.05

1.42

1.0

1.2

—

mmol/l

—

Complications of procedures, not elsewhere classified

1.74

1.40

1.0

1.1

—

mmol/l

—

Myocardial infarction, strict

2.07

1.40

1.0

1.1

—

mmol/l

—

Other chronic obstructive pulmonary disease

2.05

1.40

1.0

1.2

—

mmol/l

—

Hypertensive Heart Disease

3.16

1.40

1.0

1.3

—

Pacemaker

2.26

1.40

1.0

1.2

—

mmol/l

—

Other acute lower respiratory infections

1.90

1.40

1.1

—

mmol/l

—

Asthma, hospital admission 2, infections

1.81

1.39

1.0

1.1

—

mmol/l

—

Asthma-related infections

1.81

1.39

1.0

1.1

—

mmol/l

—

Asthma-related pneumonia

2.24

1.39

1.0

1.2

—

mmol/l

—

Asthma, hospital admissions 3, pneumonia

2.24

1.39

1.0

1.2

—

mmol/l

—

Asthma-related pneumonia or sepsis

2.24

1.39

1.0

1.2

—

mmol/l

—

Abnormal findings on examination of blood, without diagnosis

1.96

1.39

1.2

1.1

—

mmol/l

—

Pain (limb, back, neck, head abdominally)

1.85

1.38

1.2

1.1

—

mmol/l

—

COPD, hospital admissions 1, only main diagnosis

2.21

1.36

1.0

1.2

—

mmol/l

—

Nontraumatic intracranial haemmorrhage

2.61

1.36

1.0

1.2

—

mmol/l

—

Abnormal spermatozoa

2.94

1.36

1.0

1.2

—

Hypotension

2.94

1.36

1.0

1.1

—

mmol/l

—

1.92

1.35

1.0

1.1

—

mmol/l

—

Acute bronchitis

2.13

1.33

1.1

1.2

—

mmol/l

—

Extrapyramidal and movement disorders

2.14

1.33

1.2

—

mmol/l

—

Autoimmune diseases related-to ILD

106

1.65

1.32

1.1

—

mmol/l

—

Angina pectoris

1.96

1.32

1.1

—

mmol/l

—

COPD

1.99

1.31

1.0

1.2

—

mmol/l

—

Low back pain

1.69

1.31

1.1

—

mmol/l

—

malignant neoplasm of male genital organs

2.17

1.30

1.0

1.2

—

mmol/l

—

Nasal polyp

2.50

1.30

1.0

1.3

—

mmol/l

—

Other bacterial intestinal infections, including avohilmo

2.50

1.30

1.2

—

mmol/l

—

malignant neoplasm of male genital organs, including Hilmo

2.16

1.30

1.0

1.2

—

mmol/l

—

Type 1 diabetes, wide definition

2.50

1.30

1.0

1.1

—

mmol/l

—

ILD medications

1.55

1.29

1.1

—

mmol/l

—

Labour and delivery complicated by fetal stress [distress]

2.60

1.29

1.3

1.2

—

mmol/l

—

Other or unspecified ileus, impaction or obstruction

2.78

1.28

1.0

1.1

—

mmol/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.79

1.27

1.0

1.1

—

mmol/l

—

Dental caries, including avohilmo

1.87

1.27

1.4

1.0

—

mmol/l

—

Pulmonary heart disease, diseases of pulmonary circulation

2.29

1.26

1.0

1.2

—

mmol/l

—

Ischaemic heart disease, wide definition

1.73

1.26

1.2

1.1

—

mmol/l

—

Iridocyclitis

2.40

1.24

1.2

—

mmol/l

—

Abnormal serum enzyme levels

2.02

1.24

1.0

1.1

—

mmol/l

—

Otitis externa

2.40

1.24

1.0

1.3

—

mmol/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.81

1.24

1.0

1.2

—

mmol/l

—

Other diseases of pleura

1.99

1.23

1.1

1.2

—

mmol/l

—

Scabies, including avohilmo

2.63

1.21

1.0

1.2

—

mmol/l

—

Migraine with aura

2.63

1.21

1.2

1.3

—

Cardiomyopathy

2.63

1.21

1.0

1.2

—

mmol/l

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

108

1.58

1.19

1.0

1.1

—

mmol/l

—

Polyuria

2.31

1.18

1.3

1.2

—

mmol/l

—

Fibroblastic disorders

2.31

1.18

1.0

1.2

—

mmol/l

—

Other arthritis (FG)

2.11

1.18

1.1

1.2

—

mmol/l

—

Glaucoma suspect

2.10

1.18

1.3

1.1

—

mmol/l

—

Status post-ami

2.41

1.14

1.0

1.2

—

mmol/l

—

Polyarthrosis

2.50

1.14

1.0

1.1

—

mmol/l

—

AV-block

2.51

1.13

1.0

1.1

—

mmol/l

—

Dyspnoea

1.60

1.12

1.1

—

mmol/l

—

Injuries to the neck

2.33

1.12

1.0

1.3

—

mmol/l

—

Diseases of external ear

2.00

1.12

1.0

1.2

—

mmol/l

—

Caries of enamel

109

0.54

1.11

1.1

—

mmol/l

—

Irritable bowel syndrome

2.26

1.10

1.1

1.2

—

mmol/l

—

Unspecified haematuria

1.91

1.09

1.0

1.2

—

mmol/l

—

Other functional intestinal disorders

1.88

1.08

1.2

1.1

—

mmol/l

—

Dermatitis and eczema

103

1.49

1.06

1.2

1.1

—

mmol/l

—

Chronic periodontitis, including avohilmo

1.53

1.05

1.2

1.1

—

mmol/l

—

Hernia

1.54

1.05

1.2

1.1

—

mmol/l

—

Hypothyroidism, strict autoimmune

1.67

1.03

1.1

—

mmol/l

—

Diabetic retinopathy, strict definition

2.07

1.03

1.0

1.2

—

mmol/l

—

Conduction disorders

2.08

1.02

1.0

1.3

—

mmol/l

—

Obesity related asthma

1.92

1.02

1.0

1.2

—

mmol/l

—

Sleep apnoea

1.52

1.00

1.1

—

mmol/l

—

Myocardial infarction, unclassifiable

2.23

1.00

1.4

1.1

—

mmol/l

—

Propionic acid derivatives

2.52

0.99

1.0

1.1

—

mmol/l

—

Myocardial infarction, without ST-elevation

1.85

0.98

1.0

1.2

—

Other arrhythmias

1.73

0.98

1.2

1.1

—

mmol/l

—

Diseases of middle ear and mastoid

1.68

0.97

1.1

—

mmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

0.00

0.97

0.0

1.1

—

Rotator cuff syndrome

1.69

0.96

1.1

—

mmol/l

—

Seborrhoeic keratosis

0.00

0.96

0.0

1.2

—

Asthma (diagnoses ohter than nonallergic)

106

1.52

0.96

1.0

1.1

—

mmol/l

—

False labour

1.97

0.96

1.4

1.1

—

Atopic dermatitis, strict definition with reimbursement

1.92

0.95

1.3

1.1

—

mmol/l

—

Impingement syndrome of shoulder

0.00

0.95

0.0

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.46

0.94

1.1

—

mmol/l

—

Ventral hernia

2.22

0.93

1.7

1.2

—

mmol/l

—

Sleep apnoea, including avohilmo

1.48

0.92

1.1

—

mmol/l

—

Dorsalgia

1.49

0.92

1.0

1.1

—

mmol/l

—

Soft tissue disorders

1.50

0.92

1.1

—

mmol/l

—

Pedal cyclist injured in transport accident

2.14

0.91

1.2

—

mmol/l

—

Other diseases of blood and blood-forming organs, wide

2.14

0.91

1.0

1.3

—

mmol/l

—

Finngen Rheumatological endpoints

1.49

0.90

1.2

1.1

—

mmol/l

—

Shoulder lesions

1.60

0.89

1.1

—

mmol/l

—

Pure hypercholesterolaemia

1.73

0.88

1.1

—

mmol/l

—

Liquid cancers, including Hilmo

1.91

0.88

1.3

1.2

—

mmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.06

0.88

1.0

1.1

—

mmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

1.62

0.88

1.1

—

mmol/l

—

Major coronary heart disease event

1.54

0.86

1.2

1.1

—

mmol/l

—

Chronic lower respiratory diseases

101

1.41

0.84

1.0

1.1

—

mmol/l

—

Benign lipomatous neoplasm

1.94

0.84

1.2

—

mmol/l

—

Mycoses

1.94

0.84

1.2

—

mmol/l

—

Pulmonary embolism

1.94

0.84

1.0

1.2

—

mmol/l

—

Pulmonary heart disease

1.94

0.84

1.0

1.2

—

mmol/l

—

Other diseases of anus and rectum

1.93

0.84

1.3

1.1

—

mmol/l

—

Dermatophytosis, including avohilmo

109

0.54

0.83

1.0

1.1

—

mmol/l

—

Female genital prolapse

0.00

0.83

0.0

1.1

—

Visual disturbances

1.69

0.82

1.0

1.2

—

mmol/l

—

Uterine polyps

0.00

0.82

0.0

1.1

—

Other medical care

1.75

0.80

1.2

1.1

—

mmol/l

—

Unstable angina pectoris

1.70

0.80

1.1

—

mmol/l

—

Special screening examination for infectious and parasitic diseases

0.00

0.79

0.0

1.1

—

Postmenopausal bleeding

2.38

0.79

1.0

1.1

—

mmol/l

—

Certain disorders involving the immune mechanism

0.00

0.79

0.0

1.3

—

Corneal ulcer

0.00

0.79

0.0

1.2

—

Other skin changes

0.00

0.79

0.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.78

0.0

1.2

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.78

0.0

1.2

—

Seropositive rheumatoid arthritis, wide

0.00

0.78

0.0

1.2

—

DVT of lower extremities and pulmonary embolism

1.66

0.78

1.0

1.2

—

mmol/l

—

Presence of other devices

0.00

0.78

0.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.53

0.78

1.1

—

mmol/l

—

Chronic gastritis

0.00

0.77

0.0

1.1

—

Seropositive rheumatoid arthritis

0.00

0.77

0.0

1.2

—

Glaucoma

1.67

0.77

1.3

1.1

—

mmol/l

—

Other abnormal products of conception

2.19

0.76

1.0

1.2

—

mmol/l

—

Other cataract

1.67

0.75

1.1

1.2

—

mmol/l

—

Sequelae with surgical and medical care as external cause

2.08

0.74

1.0

1.3

—

mmol/l

—

Zoster [herpes zoster]

2.08

0.74

1.0

1.3

—

Superficial injury of wrist and hand

2.08

0.74

1.4

1.2

—

mmol/l

—

Pediculosis, acariasis and other infestations, including avohilmo

2.08

0.74

1.0

1.3

—

mmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

2.10

0.74

1.0

1.1

—

Obesity, other/unspecified

1.84

0.73

1.0

1.2

—

mmol/l

—

Migraine

1.69

0.72

1.1

1.2

—

Psoriasis

1.80

0.72

1.0

1.2

—

mmol/l

—

Provisional assignment of new diseases of uncertain etiology

1.55

0.72

1.1

—

mmol/l

—

Codes for special purposes

1.55

0.72

1.1

—

mmol/l

—

L02BG Aromatase inhibitors

1.98

0.72

1.0

1.1

—

Coronary atherosclerosis

1.58

0.71

1.0

1.1

—

mmol/l

—

Visual disturbances and blindness

1.58

0.71

1.0

1.2

—

mmol/l

—

Other viral diseases

1.74

0.71

1.1

1.2

—

mmol/l

—

Psoriasis vulgaris

1.92

0.70

1.0

1.3

—

Other strabismus

1.92

0.70

1.4

1.2

—

mmol/l

—

Effects of foreign body entering through natural orifice

1.67

0.68

1.0

1.2

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.67

0.68

1.4

1.0

—

mmol/l

—

1.39

0.68

1.1

—

mmol/l

—

Cough

1.63

0.67

1.0

1.1

—

mmol/l

—

Lower back pain or/and sciatica

105

1.36

0.65

1.0

1.1

—

mmol/l

—

Urticaria and erythema

1.59

0.65

1.1

1.2

—

mmol/l

—

Other extrapyramidal and movement disorders in other diseases

1.72

0.64

1.0

1.3

—

Primary open-angle glaucoma

1.72

0.63

1.0

—

mmol/l

—

Postmenopausal atrophic vaginitis

0.00

0.63

0.0

1.1

—

Disease of hard tissues of teeth, NOS

1.60

0.62

1.4

1.1

—

mmol/l

—

First line medication for Crohn's disease

1.34

0.62

1.2

1.1

—

mmol/l

—

Oxycodone

1.63

0.62

1.0

1.1

—

mmol/l

—

Appendectomy

0.58

0.62

1.2

1.1

—

mmol/l

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.62

0.0

1.1

—

Candidiasis, including avohilmo

1.67

0.61

1.0

1.2

—

mmol/l

—

Other/unspecified dorsalgia

1.61

0.61

1.0

1.1

—

mmol/l

—

Gonarthrosis,primary

1.42

0.61

1.0

1.1

—

mmol/l

—

Alzheimer’s disease (Late onset)

0.00

0.61

0.0

1.0

—

Disorders of lacrimal system

1.57

0.60

1.0

1.2

—

mmol/l

—

Lichen planus, including avohilmo

0.00

0.60

0.0

1.3

—

Cholelithiasis, broad definition with cholecystitis

1.45

0.59

1.1

—

mmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.59

0.0

1.1

—

Benign neoplasm: Sigmoid colon

0.00

0.59

0.0

1.3

—

Oral corticosteroids

101

1.33

0.58

1.1

—

mmol/l

—

Other specified/unspecified arthritis

1.71

0.57

1.2

—

mmol/l

—

Asthma, including avohilmo

105

1.31

0.56

1.1

—

mmol/l

—

Endometriosis

1.66

0.56

1.2

1.0

—

mmol/l

—

Sulfasalazine

1.67

0.56

1.3

1.2

—

mmol/l

—

Disorders of lens

1.45

0.55

1.3

1.1

—

mmol/l

—

Other viral diseases, not elsewhere classified, including avohilmo

1.57

0.54

1.2

—

mmol/l

—

Diabetic retinopathy

1.55

0.53

1.1

1.2

—

mmol/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.54

0.53

1.3

1.1

—

Transient ischemic attack

1.53

0.53

1.0

1.2

—

mmol/l

—

Ischaemic Stroke, excluding all haemorrhages

1.50

0.53

1.1

—

mmol/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.50

0.51

1.2

—

mmol/l

—

Examination and observation for other reasons

1.47

0.51

1.2

1.0

—

mmol/l

—

Zoster [herpes zoster], including avohilmo

1.40

0.51

1.1

—

mmol/l

—

Medical observation and evaluation for suspected diseases and conditions

1.44

0.50

1.1

1.0

—

mmol/l

—

Other disorders of lacrimal gland

1.46

0.50

1.0

1.2

—

mmol/l

—

Asthma, hospital admissions , main diagnosis only

110

1.34

0.49

1.0

1.1

—

mmol/l

—

Solid cancers, including Hilmo

1.36

0.49

1.1

—

mmol/l

—

Cardiodefibrillation

1.55

0.48

1.0

1.2

—

mmol/l

—

Spondylosis

1.46

0.47

1.0

1.1

—

mmol/l

—

Umbilical hernia

1.49

0.47

1.0

1.1

—

mmol/l

—

Urinary track infection

1.46

0.47

1.4

1.0

—

mmol/l

—

Gonarthrosis [arthrosis of knee](FG)

1.39

0.46

1.0

1.1

—

mmol/l

—

Coxarthrosis, primary

0.59

0.46

1.0

1.1

—

mmol/l

—

Diseases of the ear and mastoid process

1.28

0.46

1.1

—

mmol/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.62

0.45

1.0

1.1

—

mmol/l

—

Dementia, including avohilmo

1.40

0.45

1.4

1.0

—

mmol/l

—

Diabetes mellitus in pregnancy

1.67

0.44

1.0

1.2

—

mmol/l

—

Dental operations

1.45

0.44

1.2

1.1

—

mmol/l

—

Dentofacial anomalies [including malocclusion]

1.35

0.42

1.2

1.1

—

mmol/l

—

Venous thromboembolism

1.44

0.42

1.1

—

mmol/l

—

Ulcerative colitis

1.56

0.42

1.0

1.3

—

mmol/l

—

Strabismus

1.56

0.42

1.4

1.2

—

mmol/l

—

Medicines for HER+ breast cancer

1.55

0.42

1.0

1.1

—

Sulfonylureas

1.53

0.41

1.0

1.2

—

mmol/l

—

Heart failure and coronary heart disease

1.37

0.41

1.0

1.1

—

mmol/l

—

Inguinal hernia, bilateral

0.00

0.41

0.0

1.2

—

Thyroiditis, ILD-related definition

0.00

0.41

0.0

1.3

—

Mixed conductive and sensorineural hearing loss

0.00

0.41

0.0

1.1

—

Endometriosis ASRM stages 1,2

0.00

0.41

0.0

1.3

—

Perineal laceration during delivery

0.00

0.41

0.0

1.2

—

Inguinal or femoral hernia, bilateral

0.00

0.41

0.0

1.2

—

Malignant melanoma of skin, including Hilmo

0.00

0.41

0.0

1.2

—

Acne

0.00

0.41

0.0

1.1

—

Malignant neoplasm of colon, including Hilmo

0.00

0.41

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.35

0.41

1.0

1.2

—

mmol/l

—

Cholecystectomy

1.38

0.41

1.1

—

mmol/l

—

Prolonged pregnancy

0.00

0.41

0.0

1.1

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.41

0.0

1.1

—

Sarcoidosis

0.00

0.40

0.0

1.3

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.40

0.0

1.2

—

Other inflammation of eyelid

0.00

0.40

0.0

1.2

—

Recurrent aphthous stomatitis , including avohilmo

0.00

0.40

0.0

1.2

—

Endometriosis of pelvic peritoneum

0.00

0.40

0.0

1.1

—

Malignant neoplasm of breast, HER-negative

0.00

0.40

0.0

1.2

—

Malignant neoplasm of breast, HER-positive

1.43

0.39

1.0

1.1

—

Reimbursement for rheumatic diseases

1.38

0.39

1.3

1.1

—

mmol/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

1.43

0.39

1.0

1.1

—

Diseases of salivary glands

1.43

0.39

1.4

1.2

—

mmol/l

—

Chondropathies

0.00

0.39

0.0

1.3

—

Radiculopathy

0.00

0.39

0.0

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

1.36

0.38

1.1

—

mmol/l

—

Inflammatory bowel disease treatment related agents

103

1.24

0.37

1.1

—

mmol/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.35

0.37

1.4

1.2

—

mmol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

1.35

0.37

1.4

1.2

—

mmol/l

—

Symptoms and signs involving speech and voice

1.35

0.37

1.2

—

mmol/l

—

Malignant neoplasm of prostate

1.48

0.37

1.0

1.2

—

Dementia

1.46

0.36

1.3

1.0

—

mmol/l

—

Malignant neoplasm of prostate, including Hilmo

1.42

0.36

1.0

1.2

—

Osteopathies and chondropathies

1.36

0.35

1.0

1.1

—

mmol/l

—

Diaphragmatic hernia

1.40

0.35

1.3

1.1

—

mmol/l

—

Other diseases of hard tissues of teeth

1.40

0.34

1.5

1.1

—

mmol/l

—

Retinal detachments and breaks

1.36

0.34

1.0

1.2

—

mmol/l

—

Arthropathies

1.26

0.32

1.2

1.1

—

mmol/l

—

Other diseases of lip and oral mucosa

1.35

0.31

1.1

1.2

—

Malignant neoplasm, including Hilmo

1.26

0.31

1.1

—

mmol/l

—

Degeneration of macula and posterior pole

1.32

0.31

1.0

1.2

—

mmol/l

—

Mycoses, including avohilmo

117

0.78

0.31

1.1

—

mmol/l

—

Gonarthrosis, primary, with knee surgery

1.34

0.30

1.0

1.2

—

mmol/l

—

Temporomandibular joint disorders, including avohilmo

1.28

0.30

1.3

1.1

—

mmol/l

—

Cholelithiasis

1.29

0.30

1.1

—

mmol/l

—

Peripheral artery disease

1.26

0.29

1.0

1.2

—

Papulosquamous disorders

1.25

0.29

1.0

1.2

—

mmol/l

—

Persons encountering health services for examination and investigation

1.31

0.29

1.3

1.0

—

mmol/l

—

Other and unspecified tonsillitis

1.24

0.29

1.0

1.1

—

Malignant neoplasm, wide definition

1.24

0.28

1.1

—

mmol/l

—

Hypothyroidism, other/unspecified

1.23

0.28

1.1

—

mmol/l

—

Acute sinusitis

1.32

0.28

1.0

1.1

—

mmol/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.24

0.27

1.1

—

mmol/l

—

Coxarthrosis [arthrosis of hip](FG)

0.69

0.26

1.0

1.1

—

mmol/l

—

Diseases of oral cavity, salivary glands and jaws

1.25

0.26

1.2

1.1

—

Diseases of the musculoskeletal system and connective tissue

1.32

0.25

1.1

—

mmol/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.21

0.25

1.1

—

mmol/l

—

Disorders of conjunctiva

107

0.80

0.25

1.0

1.1

—

mmol/l

—

Diseases of male genital organs

1.24

0.24

1.1

—

mmol/l

—

Fracture of forearm

1.28

0.24

1.0

1.1

—

mmol/l

—

Solid cancers

1.22

0.24

1.1

—

mmol/l

—

Malignant neoplasm

1.22

0.23

1.1

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.32

0.23

1.0

1.2

—

mmol/l

—

Diverticular disease of intestine

0.75

0.23

1.1

—

mmol/l

—

Any dementia

1.28

0.23

1.4

1.0

—

mmol/l

—

Atopic dermatitis, strict definition

1.29

0.23

1.4

1.2

—

mmol/l

—

Gonarthrosis

1.27

0.23

1.0

1.1

—

mmol/l

—

Chronic periodontitis, complicated

1.27

0.22

1.3

1.1

—

mmol/l

—

Disorders of thyroid, IBD co-morbidities

0.00

0.22

0.0

1.0

—

Tonsillectomy and adenotomy

1.25

0.22

1.2

1.1

—

mmol/l

—

Other dorsopathies, not elsewhere classified

0.82

0.22

1.2

1.1

—

mmol/l

—

Fenamates

0.00

0.22

0.0

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.20

0.21

1.0

1.1

—

mmol/l

—

Neoplasms

1.20

0.21

1.3

1.1

—

mmol/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

1.1

—

Crohn disease (strict definition, require KELA)

0.00

0.21

0.0

1.1

—

Thyroiditis

0.00

0.21

0.0

1.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

1.1

—

Crohn's disease of small intestine

0.00

0.21

0.0

1.1

—

Malignant neoplasm of endocrine gland

0.00

0.21

0.0

1.2

—

Chronic suppurative otitis media, including avohilmo

0.00

0.21

0.0

1.1

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.1

—

Other follicular disorders

0.00

0.21

0.0

1.2

—

Other and/or unspecified nontoxic goitre

0.00

0.21

0.0

1.2

—

Foreign body entering into or through eye or natural orifice

0.00

0.21

0.0

1.1

—

Other congenital malformations of skin, including avohilmo

0.00

0.21

0.0

1.2

—

Malignant neoplasm of endocrine gland, including Hilmo

0.00

0.21

0.0

1.3

—

Sicca syndrome [Sjögren]

0.00

0.21

0.0

1.2

—

Conductive hearing loss, unspecified

0.00

0.21

0.0

1.1

—

Other peripheral vascular diseases

0.00

0.21

0.0

1.1

—

Melanocytic naevi, other sites/unspecified

0.00

0.21

0.0

1.1

—

Other congenital malformations

0.00

0.21

0.0

1.2

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

1.1

—

Aortic valve malfunction, age under 60 years

0.00

0.21

0.0

1.3

—

Amiodarone users

0.00

0.21

0.0

1.2

—

Other diseases of arteries and capillaries

0.00

0.21

0.0

1.0

—

Acne vulgaris

0.00

0.21

0.0

1.2

—

Carcinoma in situ of cervix uteri

0.00

0.21

0.0

1.3

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.3

—

Malignant melanoma of skin

0.00

0.21

0.0

1.1

—

Colon adenocarcinoma

0.00

0.21

0.0

1.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.21

0.0

1.0

—

Haemorrhoids and perianal venous thrombosis

1.18

0.21

1.0

1.1

—

mmol/l

—

Hypopituitarism

0.00

0.21

0.0

1.1

—

Overexertion and strenuous or repetitive movements

0.00

0.21

0.0

1.1

—

Benign neoplasm of breast

0.00

0.21

0.0

1.3

—

Colon adenocarcinoma, helper endpoint

0.00

0.21

0.0

1.2

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.2

—

Unspecified lump in breast

0.00

0.21

0.0

1.2

—

Malignant neoplasm of colon

0.00

0.21

0.0

1.0

—

Inflammatory bowel disease

1.16

0.21

1.0

1.2

—

mmol/l

—

Eustachian salpingitis and obstruction

0.00

0.21

0.0

1.1

—

Sudden idiopathic hearing loss

0.00

0.21

0.0

1.2

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.21

0.0

1.2

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.2

—

Other metabolic disorders

0.00

0.21

0.0

1.2

—

Allergic contact dermatitis

0.00

0.21

0.0

1.2

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.2

—

Percutaneous Coronary Intervention

1.22

0.20

1.0

1.1

—

mmol/l

—

Special screening examination for neoplasms

0.00

0.20

0.0

1.1

—

Spermatocele

0.00

0.20

0.0

1.1

—

Graves disease, strict definition

0.00

0.20

0.0

1.3

—

Melanocytic naevi of trunk

0.00

0.20

0.0

1.3

—

Lichen planus

0.00

0.20

0.0

1.1

—

Parkinson's disease, strict definition

0.00

0.20

0.0

1.1

—

Thyrotoxicosis with diffuse goitre

0.00

0.20

0.0

1.2

—

Other congenital malformations, including avohilmo

0.00

0.20

0.0

1.2

—

Coronary revascularization (ANGIO or CABG)

1.21

0.20

1.0

1.1

—

mmol/l

—

Triptan medication for migraine, single purchase ok

1.20

0.20

1.2

1.1

—

mmol/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.20

0.20

1.2

1.1

—

mmol/l

—

Cervical disc disorders

1.20

0.19

1.3

1.2

—

mmol/l

—

Irregular menses

1.15

0.19

1.5

1.1

—

mmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.19

0.18

1.0

1.2

—

mmol/l

—

Other viral diseases, including avohilmo

1.17

0.18

1.1

1.2

—

mmol/l

—

Striking against or struck by other objects

1.16

0.17

1.0

1.1

—

mmol/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.21

0.17

1.1

—

mmol/l

—

Other specific joint derangements/joint disorders

1.19

0.17

1.0

1.1

—

mmol/l

—

Atopic dermatitis

1.22

0.17

1.3

1.1

—

mmol/l

—

ILD medications: immunosuppressive drugs

1.19

0.17

1.2

1.1

—

mmol/l

—

Abnormal findings on diagnostic imaging of lung

0.75

0.17

1.0

1.1

—

mmol/l

—

Conjunctivitis

0.83

0.17

1.0

1.1

—

mmol/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.16

0.16

1.0

1.2

—

mmol/l

—

Malignant neoplasm of skin, including Hilmo

1.12

0.16

1.0

1.1

—

mmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.21

0.16

1.5

1.0

—

mmol/l

—

Allergic conjunctivitis

1.11

0.16

1.0

1.1

—

mmol/l

—

Benign neoplasm: Colon

1.10

0.16

1.3

1.1

—

mmol/l

—

Acute upper respiratory infections

1.14

0.15

1.1

—

mmol/l

—

Disorders of eyelid, lacrimal system and orbit

0.85

0.15

1.0

1.1

—

mmol/l

—

Other disorders of ear

1.15

0.15

1.1

—

mmol/l

—

Other disorders of skin and subcutaneous tissue

1.18

0.15

1.0

1.1

—

mmol/l

—

Diseases of appendix

106

0.84

0.14

1.4

1.1

—

mmol/l

—

Carpal tunnel syndrome

0.80

0.14

1.1

—

mmol/l

—

Appendicitis, broad definition

106

0.85

0.14

1.4

1.1

—

mmol/l

—

Other joint disorders

1.15

0.13

1.2

1.1

—

mmol/l

—

L04AX Other immunosuppressants

1.19

0.13

1.0

1.1

—

mmol/l

—

Acute appendicitis, no complications

0.80

0.13

1.4

1.1

—

mmol/l

—

Excessive attrition of teeth

1.17

0.13

1.3

1.1

—

mmol/l

—

Nerve, nerve root and plexus disorders

102

1.12

0.12

1.1

—

mmol/l

—

Asthma/COPD (KELA code 203)

101

1.12

0.12

1.1

—

mmol/l

—

Gingivitis and periodontal diseases

0.88

0.12

1.3

1.1

—

mmol/l

—

Malignant neoplasm

1.14

0.11

1.1

—

mmol/l

—

Second line medication for Crohn's disease

1.16

0.10

1.0

1.1

—

mmol/l

—

Embedded and impacted teeth

1.16

0.10

1.0

1.1

—

Sequelae of cerebrovascular disease

1.15

0.10

1.0

1.2

—

mmol/l

—

Abrasion of teeth

1.14

0.10

1.0

1.2

—

mmol/l

—

1.10

0.09

1.0

1.1

—

mmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1.07

0.09

1.0

1.2

—

Malignant neoplasm of breast, including Hilmo

1.07

0.09

1.0

1.2

—

Disorders of breast

1.07

0.09

1.4

1.1

—

Internal derangement of knee

1.08

0.09

1.0

1.2

—

Malignant neoplasm of digestive organs

1.06

0.09

1.0

1.2

—

mmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.03

0.09

1.0

1.2

—

mmol/l

—

Valvular heart disease excluding rheumatic fever

1.13

0.09

1.0

1.2

—

mmol/l

—

Non-rheumatic valve diseases

1.13

0.09

1.0

1.2

—

mmol/l

—

Presence of cardiac and vascular implants and grafts

1.10

0.09

1.0

1.2

—

mmol/l

—

Disorders of vestibular function (Vertigo)

1.08

0.08

1.0

1.1

—

mmol/l

—

Acute appendicitis

105

0.88

0.08

1.4

1.1

—

mmol/l

—

Coxarthrosis

0.79

0.08

1.0

1.1

—

mmol/l

—

Lumbar disc prolapse

1.13

0.08

1.2

1.1

—

mmol/l

—

Malignant neoplasm of skin

1.03

0.08

1.0

1.2

—

mmol/l

—

Mouth breathing

1.04

0.08

1.1

—

mmol/l

—

Pain in joint

1.09

0.07

1.0

1.1

—

mmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.09

0.07

1.3

1.1

—

Sciatica+with lumbago

1.09

0.07

1.1

—

mmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

0.88

0.07

1.3

1.1

—

mmol/l

—

Sensorineural hearing loss

1.11

0.06

1.2

1.1

—

mmol/l

—

Senile cataract

1.13

0.06

1.3

1.1

—

mmol/l

—

Arthrosis

1.12

0.06

1.0

1.1

—

mmol/l

—

Artrosis, including avohilmo

0.91

0.05

1.3

1.1

—

mmol/l

—

Artificial joint operation, meniscal resection

1.08

0.04

1.1

—

mmol/l

—

Conductive and sensorineural hearing loss

1.08

0.03

1.2

1.1

—

mmol/l

—

Chronic diseases of tonsils and adenoids

1.06

0.02

1.1

—

mmol/l

—

Dorsopathies

1.05

0.02

1.1

—

mmol/l

—

Disorders of the thyroid gland

1.05

0.01

1.1

—

mmol/l

—

Benign neoplasms

0.96

0.00

1.2

1.1

—

mmol/l

—

Other intervertebral disc disorders

0.99

0.00

1.2

1.1

—

mmol/l

—

Conjunctivitis (acute, non atopic), including avohilmo

104

0.99

0.00

1.3

1.1

—

mmol/l

—

Inguinal hernia

1.04

0.00

1.2

1.1

—

mmol/l

—

Emergency coronary revascularization (for ACS)

1.02

0.00

1.0

1.1

—

mmol/l

—

Any event in cancer register

1.03

0.00

1.1

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.99

0.00

1.2

1.1

—

mmol/l

—

Symptoms and signs involving the skin and subcutaneous tissue

103

1.01

0.00

1.3

1.1

—

mmol/l

—

Pedestrian injured in collision with pedal cycle

0.00

0.0

1.2

—

Excessive vomiting in pregnancy

0.00

0.0

1.1

—

L01XE Protein kinase inhibitors

0.00

0.0

1.0

—

Benign neoplasm: Stomach

0.00

0.0

1.0

—

Abnormalities of forces of labour

0.00

0.0

1.3

—

Pustular psoriasis

0.00

0.0

1.0

—

Certain conditions originating in the perinatal period

0.00

0.0

1.1

—

Asthma and allergy, excluding more controls

0.00

0.0

1.4

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.0

1.1

—

Crohn's disease NAS

0.00

0.0

1.1

—

Asthma and opportunity respiratory infection

0.00

0.0

1.0

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

0.0

1.2

—

Carcinoma in situ of other and unspecified digestive organs

0.00

0.0

1.0

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

0.0

1.0

—

Other noninflammatory disorders of cervix uteri

0.00

0.0

1.2

—

Other vitreous opacities

0.00

0.0

1.0

—

Viral meningitis

0.00

0.0

1.0

—

L01XX Other antineoplastic agents

0.00

0.0

1.0

—

Pericarditis

0.00

0.0

1.0

—

Other specified and unspecified retinal disorders

0.00

0.0

1.0

—

Other necrotizing vasculopathies (FG)

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.3

—

Corns and callosities

0.00

0.0

1.0

—

Extracorporeal dialysis

0.00

0.0

1.1

—

Varicose veins of other sites

0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland, including Hilmo

0.00

0.0

1.2

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

Autoimmune hyperthyroidism

0.00

0.0

1.3

—

Polycystic ovarian syndrome, consortium definition

0.91

0.00

1.4

1.1

—

mmol/l

—

Golimumab

0.00

0.0

1.2

—

Vestibular neuronitis

0.00

0.0

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

0.97

0.00

1.5

1.0

—

mmol/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

0.0

1.0

—

Chronic iridocyclitis

0.00

0.0

1.1

—

Acute lymphadenitis

0.00

0.0

1.1

—

Ovarian dysfunction

0.00

-0.00

0.0

1.3

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.2

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

1.1

—

0.00

-0.00

0.0

1.3

—

Other and unspecified follicular disorders

0.00

-0.00

0.0

1.0

—

Other and unspecified erythematous conditions

0.00

-0.00

0.0

1.2

—

Other erythematous conditions

0.00

-0.00

0.0

1.2

—

Other disorders of pigmentation

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of pancreas, including Hilmo

0.00

-0.00

0.0

1.0

—

Osteomyelitis

0.00

-0.00

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

1.2

—

Other diseases of peritoneum

0.00

-0.00

0.0

1.0

—

Macular cyst

0.00

-0.00

0.0

1.0

—

Macular hole

0.00

-0.00

0.0

1.0

—

Myeloproliferative diseases (CML excluded)

0.00

-0.00

0.0

1.0

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri

0.00

-0.00

0.0

1.4

—

Female infertility, tubal origin

0.00

-0.00

0.0

1.2

—

Papillary adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

Female infertility, associated with anovulation

0.00

-0.00

0.0

1.1

—

Impacted maxillary molar

0.00

-0.00

0.0

1.0

—

Kidney transplant status

0.00

-0.00

0.0

1.1

—

Normotensive glaucoma

0.00

-0.00

0.0

1.0

—

Other osteochondropathies

0.00

-0.00

0.0

1.2

—

Pathological resorption of teeth

0.00

-0.00

0.0

1.1

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

1.0

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.1

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Other diseases of stomach and duodenum

0.00

-0.00

0.0

1.0

—

Foreign body in respiratory tract

0.00

-0.00

0.0

1.0

—

Pleural plaque with presence of asbestos

0.00

-0.00

0.0

1.3

—

Disorders resulting from impaired renal tubular function

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Descending colon

0.00

-0.00

0.0

1.0

—

Glucosamine medication

0.97

-0.00

1.0

1.1

—

mmol/l

—

Lichen simplex chronicus

0.00

-0.00

0.0

1.0

—

Hypertrophic scar

0.00

-0.00

0.0

1.1

—

Other and unspecified mononeuropathies of upper limb

0.00

-0.00

0.0

1.2

—

Pustulosis palmaris et plantaris

0.00

-0.00

0.0

1.0

—

Anisometropia and aniseikonia

0.00

-0.00

0.0

1.1

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.1

—

Tuberculosis, IBD comorbidity

0.00

-0.00

0.0

1.0

—

Radial styloid tenosynovitis [de Quervain]

0.00

-0.00

0.0

1.1

—

Juvenile osteochondrosis

0.00

-0.00

0.0

1.2

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Other and unspecified parts of mouth

0.00

-0.00

0.0

1.0

—

Benign neoplasm of other and unspecified sites

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Parotid gland

0.00

-0.00

0.0

1.1

—

Carcinoma in situ of colon

0.00

-0.00

0.0

1.0

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

1.0

—

Carcinoma in situ, bladder

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

1.1

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Melanoma in situ

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of other and unspecified sites

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin

0.00

-0.00

0.0

1.0

—

Noise effects on inner ear

0.00

-0.00

0.0

1.0

—

Crohn's disease of large intestine

0.00

-0.00

0.0

1.1

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.1

—

Meralgia paraesthetica

0.00

-0.00

0.0

1.0

—

Peripheral retinal degeneration

0.00

-0.00

0.0

1.0

—

Vertical strabismus

0.00

-0.00

0.0

1.2

—

Asthma and allergy

0.00

-0.00

0.0

1.4

—

Other acute skin changes due to ultraviolet radiation

0.00

-0.00

0.0

1.0

—

Chronic suppurative otitis media

0.00

-0.00

0.0

1.0

—

Herpesviral keratitis and keratoconjunctivitis

0.00

-0.00

0.0

1.0

—

Other infective otitis externa

0.00

-0.00

0.0

1.1

—

Congenital malformations of genital organs

0.00

-0.00

0.0

1.2

—

Congenital malformations of the urinary system, including avohilmo

0.00

-0.00

0.0

1.1

—

Dermatographic urticaria

0.00

-0.00

0.0

1.1

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.2

—

Care involving dialysis

0.00

-0.00

0.0

1.2

—

Other noninflammatory disorders of vagina

0.00

-0.00

0.0

1.1

—

Diseases of arteries, arterioles and capillaries

0.94

-0.00

1.0

1.1

—

mmol/l

—

Hyperplasia of prostate

0.91

-0.00

1.0

1.1

—

mmol/l

—

Amblyopia ex anopsia

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of ovary, including Hilmo

0.00

-0.00

0.0

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.00

-0.00

0.0

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

-0.00

0.0

1.4

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Lactose intolerance

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

1.4

—

Postpartum haemorrhage due to anatomy

0.00

-0.00

0.0

1.3

—

Other obstetric trauma

0.00

-0.00

0.0

1.5

—

Glaucoma secondary to other eye disorders

0.00

-0.00

0.0

1.2

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.2

—

Memory loss

0.00

-0.00

0.0

1.0

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.2

—

Neovascular glaucoma

0.00

-0.00

0.0

1.2

—

Other disorders of nervous system

0.00

-0.00

0.0

1.0

—

Ménière disease

0.00

-0.00

0.0

1.0

—

Other disorders involving the immune mechanism, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Immunodeficiencies

0.00

-0.00

0.0

1.2

—

Separation of retinal layers (serosa)

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of trunk

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Larynx

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.2

—

Other maternal disorders predominantly related to pregnancy

0.87

-0.00

1.2

1.1

—

mmol/l

—

Other, unspecified and serous retinal detachments

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of digestive organs, including Hilmo

0.90

-0.00

1.0

1.2

—

mmol/l

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

1.0

—

Diseases of inner ear

1.00

-0.00

1.0

1.1

—

mmol/l

—

Lymphoid leukaemia

0.00

-0.00

0.0

1.1

—

Scleritis and episcleritis

0.00

-0.00

0.0

1.1

—

Cardiomyopathy, other and unspecified

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of pancreas

0.00

-0.00

0.0

1.0

—

Spinal stenosis

0.90

-0.00

1.0

1.1

—

mmol/l

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

1.2

—

Left bundle-branch block

0.00

-0.00

0.0

1.0

—

Atypical facial pain

0.00

-0.00

0.0

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

0.90

-0.00

1.3

1.1

—

mmol/l

—

Disorders of sclera, cornea, iris and ciliary body

0.98

-0.00

1.4

1.1

—

mmol/l

—

Recurrent dislocation of patella

0.00

-0.00

0.0

1.4

—

Meniscus derangement

0.91

-0.00

1.1

—

mmol/l

—

Pregnancy with abortive outcome

0.87

-0.00

1.0

1.1

—

Excessive earwax

0.98

-0.00

1.0

1.1

—

mmol/l

—

Viral meningitis, including avohilmo

0.00

-0.00

0.0

1.0

—

Raynaud syndrome

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Tuberculosis, wide

0.00

-0.00

0.0

1.0

—

Tuberculosis, wide, including avohilmo

0.00

-0.00

0.0

1.0

—

Other and unspecified coagulation defects

0.00

-0.00

0.0

1.1

—

Other coagulation defects

0.00

-0.00

0.0

1.1

—

Hyperaldosteronism

0.00

-0.00

0.0

1.0

—

Disorders of orbit

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.1

—

Vasomotor rhinitis (mode)

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Long bones of lower limb

0.00

-0.00

0.0

1.2

—

Medial epicondylitis

0.00

-0.00

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

-0.00

0.0

1.0

—

Unspecified urinary incontinence

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the circulatory and respiratory systems

0.00

-0.00

0.0

1.0

—

Pneumonia derived septicemia

0.00

-0.00

0.0

1.2

—

Ulcerative enterocolitis

0.00

-0.00

0.0

1.0

—

Other abnormal findings of blood chemistry

0.00

-0.00

0.0

1.0

—

Cramp and spasm

0.00

-0.00

0.0

1.0

—

L02BX Other hormone antagonists and related agents

0.00

-0.00

0.0

1.4

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

0.00

-0.00

0.0

1.0

—

Other and unspecified corneal deformities and disorders

0.00

-0.00

0.0

1.0

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

1.2

—

Episcleritis

0.00

-0.00

0.0

1.0

—

Other secondary coxarthrosis

0.00

-0.00

0.0

1.0

—

Mandibular retrognathia

0.00

-0.00

0.0

1.1

—

Oral leukoplakia, including avohilmo

0.00

-0.00

0.0

1.0

—

Pneumococcal septicemia

0.00

-0.00

0.0

1.2

—

Use of antiglaucoma preparations and miotics

0.00

-0.00

0.0

1.2

—

Triptan medication for migraine, min. 3 purchases

0.89

-0.00

1.4

1.1

—

mmol/l

—

Laparoscopic right hemicolectomy

0.00

-0.00

0.0

1.0

—

Fall on and from ladder

0.00

-0.00

0.0

1.1

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

-0.00

0.0

1.2

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.1

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

1.1

—

Desensitization to allergens

0.00

-0.00

0.0

1.3

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.3

—

Failed induction of labour

0.00

-0.00

0.0

1.2

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

1.1

—

Other disorders of eyelid

0.98

-0.00

1.0

1.2

—

Inflammatory disease of cervix uteri

0.00

-0.00

0.0

1.2

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

1.2

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

-0.00

0.0

1.2

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

1.3

—

Polypectomy (DHB20)

0.00

-0.00

0.0

1.0

—

Need for other prophylactic measures

0.00

-0.00

0.0

1.1

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

-0.00

0.0

1.1

—

Acute bronchiolitis

0.00

-0.00

0.0

1.2

—

Unspecified abortion

0.00

-0.00

0.0

1.6

—

Pleural plaque

0.00

-0.00

0.0

1.2

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Other necrotizing vasculopathies

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ethylene glycol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS